inj
Telegram Prohibited from Issuing Gram Tokens as US Court Grants SEC's Injunction
A United States District Court has sided with the US Securities and Exchange Commission (SEC) granting an injunction against Telegram to to temporarily prevent the company from issuing its Gram tokens.
Telegram Appeals Federal Court Injunction to Stop Gram Distribution
Telegram has filed an appeal to yesterday’s ruling by a United Stated federal court in favour of the US Securities and Exchange Commission (SEC) which has prohibited the issuance of Gram tokens for the time being.
Arkham Intelligence Announces Partnership with Ninja Traders
Arkham partners with Ninja Traders to offer best-in-class onchain data, tooling, and analysis to crypto traders.
Injective (INJ)Unveils Helix 2.0 and Other Key Updates in May
Injective (INJ)showcases significant advancements with the launch of Helix 2.0 and other key updates in May.
Comprehensive Guide to Developing and Trading on Injective (INJ)
Explore Injective's tools for smart contracts, frontend development, and API trading.
Gaming Giant gumi Joins Injective (INJ) as Validator
gumi, a top Web2 gaming publisher, joins Injective (INJ)as a validator, bolstering Injective's PoS network.
Injective (INJ) Partners with The Graph to Enhance Open Data Accessibility
Injective (INJ)integrates with The Graph to offer developers enhanced access to on-chain data, fostering the creation of sophisticated dApps.
Comprehensive Guide to Launching a dApp on Injective
Learn how to launch a decentralized application (dApp) on Injective, from installing injectived to deploying smart contracts and building a frontend.
Injective (INJ)Announces Groundbreaking Developments in June Community Update
Injective's June Community Update highlights significant progress, including the launch of the Injective (INJ)Builder House event.
Injective's First Builder House Event Garners Industry Acclaim
The inaugural Injective (INJ)Builder House in Brussels during EthCC united developers, industry leaders, and community members, marking a key milestone for Injective.
Injective (INJ) Unveils New Staking ETP in Collaboration with 21Shares
Injective (INJ)collaborates with 21Shares to launch AINJ, a new staking ETP offering INJ exposure and staking rewards via traditional finance venues.
Injective (INJ) Integrates Mountain Protocol to Introduce Tokenized T-Bills
Injective (INJ)has integrated with Mountain Protocol to launch USDM, a yield-bearing stablecoin, enhancing the DeFi ecosystem with tokenized treasury bills.
Injective (INJ) Unveils Altaris Mainnet Upgrade with Enhanced Capabilities
Injective (INJ)launches Altaris mainnet upgrade, promising enhanced scalability, new developer tools, and improved economic structure.
Injective (INJ) Community Update Highlights July Milestones
Injective's July Community Update details significant milestones, including the success of the Injective (INJ)Builder House during EthCC.
Injective (INJ) Launches 'Altaris' Upgrade Featuring Advanced RWA Oracle and Enhanced Burn Auction
Injective (INJ)blockchain has successfully deployed the 'Altaris' upgrade, enhancing the ecosystem with advanced RWA Oracle, improved burn auction mechanics, and new developer tools.
Injective (INJ) Achieves Major Performance Milestone with 0.65-Second Block Times
Injective (INJ) slashes block times to 0.65 seconds, setting new standards in blockchain performance and scalability.
Exploring Binary Options on Injective: A Comprehensive Analysis
Discover how Injective's binary options markets offer developers robust tools for creating diverse decentralized applications (dApps).
Binance to Support Injective (INJ) Network Upgrade and Hard Fork
Binance to suspend deposits and withdrawals for Injective (INJ) network during its upgrade and hard fork on August 20, 2024.
Balanced Integrates Injective (INJ) to Enhance Cross-Chain DeFi
Balanced, a cross-chain DeFi platform, integrates with Injective, introducing the bnUSD stablecoin and expanding DeFi capabilities.
Injective (INJ)Launches Remix Web IDE for Seamless Smart Contract Development
Injective (INJ)introduces the Remix Web IDE plugin, streamlining smart contract development directly from the web browser.
Injective (INJ)Launches Tokenized Index for BlackRock's BUIDL Fund
Injective (INJ)introduces the first-ever tokenized index for BlackRock's BUIDL Fund, offering innovative on-chain financial instruments to users.
Injective (INJ)Partners with Mercuryo for Seamless Onboarding
Injective (INJ)collaborates with Mercuryo to streamline user onboarding through a new fiat on-ramp payment solution.
Injective (INJ) Celebrates Successful August with Major Updates and Events
The Injective (INJ) community witnessed significant developments in August, including a major chain upgrade and the successful Injective Builder House event in Brussels.
Mercuryo Integrates Fiat On-Ramp with Injective (INJ) Bridge
Mercuryo partners with Injective (INJ)to streamline fiat-to-crypto transactions, easing user onboarding to the Injective ecosystem.
Highlights from Token2049: Injective's Dynamic Presence in Singapore
At Token2049, Injective (INJ)impressed with keynotes, panels, and engaging activities, showcasing its influence in the web3 space.
Paxos Launches Yield-Bearing Stablecoin on Injective (INJ)Network
Paxos introduces Wrapped Lift Dollar (wUSDL) on the Injective (INJ)Network, offering users a stablecoin that earns yield from treasury bills, enhancing DeFi interactions.
NTT Digital Expands Web3 Presence by Joining Injective (INJ)as a Validator
NTT Digital, part of Japan's largest telecom, joins Injective (INJ)as a validator, enhancing the blockchain's security and expanding its influence in Asia's Web3 market.
Injective (INJ)and Fetch Collaborate to Advance AI-Driven Finance with ASI
Injective (INJ)and Fetch.ai join forces with the Artificial Superintelligence Alliance to enhance AI-enabled finance on the Injective platform, marking a significant step in blockchain interoperability.
Agora Introduces AUSD Stablecoin on Injective (INJ)Blockchain
Agora launches AUSD, a US dollar-backed stablecoin, on the Injective (INJ)blockchain, enhancing liquidity between DeFi and TradFi markets, and supporting seamless financial transactions.
Injective's October Updates Highlight Advancements in TradFi and DeFi Integration
Injective's October 2024 update reveals significant advancements in blockchain, ecosystem, and community sectors, aiming to merge traditional finance with decentralized finance.
Hex Trust Enhances Custody and Trading Services for Injective (INJ)
Hex Trust expands its custody, staking, and trading services to the Injective (INJ)ecosystem, strengthening its role as a validator and supporting institutional investors.
Injective (INJ)Summit Highlights: A Glimpse into the Future of Finance
The Injective (INJ)Summit in Bangkok attracted nearly 1,000 attendees and featured over 30 industry leaders, showcasing pivotal innovations in finance.
Injective (INJ)and Aethir Transform GPU Compute Resources with Tokenization
Injective (INJ)and Aethir collaborate to tokenize GPU compute resources, enhancing access and efficiency in AI and blockchain sectors through a novel tradeable token system.
Injective (INJ)and SVM Sonic to Launch Crosschain AI Hub
Injective (INJ)and SVM Sonic are collaborating to introduce the Smart Agent Hub, enabling crosschain AI applications and cryptocurrency bridging between Solana and Injective.
Injective (INJ)Launches iAgent 2.0 to Revolutionize AI-Agent Development
Injective (INJ)introduces iAgent 2.0, an advanced AI agent framework enhancing on-chain capabilities, scalability, and interoperability, integrating Eliza's framework with Injective’s infrastructure.
Injective's Role in the Real-World Asset Tokenization Boom
Injective (INJ)is at the forefront of the real-world asset tokenization revolution, leveraging blockchain technology to offer innovative financial solutions and collaborations with major institutions.
Injective (INJ)and ElizaOS Launch AI Agent Hackathon with $100K Prize Pool
Injective, in collaboration with ElizaOS and Dorahacks, is hosting an AI Agent Hackathon offering over $100,000 in prizes and support from top developers.
KDAC Expands into Blockchain with Validator Role on Injective
Korea Digital Asset Custody (KDAC) has joined Injective (INJ)as a validator, enhancing security and scalability in the blockchain ecosystem, and signaling a shift towards decentralized technologies in Asia.
Injective (INJ)Hub V2 Launches with Enhanced Features for Users
Injective (INJ)Hub V2 introduces a revamped design and improved user experience, offering seamless access to the Injective ecosystem. Discover new features including enhanced onboarding and streamlined navigation.
Injective (INJ)Unveils New Brand Identity as It Enters Next Growth Phase
Injective (INJ)announces a new brand identity, marking a significant evolution as it defines its future direction. The rebranding aligns with recent achievements and sets the stage for upcoming initiatives.
Injective (INJ)Unveils Enhanced Blockchain Explorer, InjScan
Injective (INJ)introduces InjScan, a revamped blockchain explorer enhancing user experience with new features like advanced smart contract tools and improved data visualization.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Bullish Breakout
Injective (INJ) surged 15% this week, breaking a multi-month bearish trend. With its EVM testnet launch, rising adoption, and bullish technical momentum, INJ eyes $15+.
Injective (INJ) Surges 15% Amid EVM Testnet Launch and Strategic Partnerships
Injective (INJ) gains momentum with a 15% price surge, driven by its EVM testnet launch, soaring on-chain activity, and strategic partnerships with Google Cloud and Deutsche Telekom.
Injective (INJ): EVM Testnet Launch, Strategic Partnerships, and Bullish Momentum in 2025
Injective (INJ) gains momentum with its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and bullish price action above $13.50.
Injective (INJ) Gains Momentum: EVM Testnet, Partnerships, and Bullish Price Trends
Injective (INJ) surges with its EVM testnet launch, partnerships with Google Cloud and Deutsche Telekom, and a potential 3x rally. Here's what traders need to know.
Injective (INJ) Rallies 15%: EVM Testnet Launch and Strategic Partnerships Drive Growth
Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and growing DeFi adoption.
Injective (INJ) Gains Momentum with EVM Testnet, Institutional ETF Filing, and Strategic Partnerships
Injective (INJ) pushes forward with bullish developments, including an EVM testnet launch, institutional ETF filing, and regulatory collaboration, signaling long-term growth prospects.
Injective (INJ) Surges 15% on EVM Testnet Launch and Strategic Partnerships: Technical Analysis & Price Outlook
Injective rallies 15% following EVM testnet launch and partnerships with Google Cloud and Deutsche Telekom. Technical indicators suggest continued bullish momentum.
Injective (INJ) Surges 14% Above Resistance as Bulls Target $15.48 - Technical Breakout Analysis
Injective breaks multi-week downtrend with strong momentum, trading at $14.23 after key resistance breakouts. Technical indicators signal continued bullish momentum.
Injective (INJ) Surges on EVM Testnet Launch Amid Bullish Momentum: Price Outlook and Key Insights
Injective (INJ) sees a 15% surge following the EVM testnet launch and bullish technical breakout. With a teased announcement on July 17, market sentiment remains high.
Injective (INJ) Breaks $15 Resistance as Bulls Target $15.48 on EVM Testnet Momentum
INJ surges to $15.19 (+6.75%) breaking multi-week downtrend with RSI at 72.96 showing overbought conditions as EVM testnet launch and strategic partnerships fuel bullish momentum.
Injective (INJ) Maintains Bullish Momentum Near $15 After 14% Surge
INJ trades at $14.83 with strong bullish signals as technical breakout and strategic partnerships drive sustained momentum toward $15.71 resistance level.
Injective (INJ) Holds Above $13 as Bulls Eye $15.71 Resistance Target
INJ trades at $13.92 (+0.58% daily) with strong bullish momentum intact following recent 14% surge and technical breakout above key resistance levels.
Injective (INJ) Tests $13.31 Support After Breaking Multi-Week Downtrend
INJ trades at $13.31 (-1.48% in 24h) as bulls defend key support following last week's 14% surge driven by EVM testnet launch and major partnerships.
Injective (INJ) Surges 6.38% as Bulls Defend Key Support Above $14
INJ trades at $14.18 (+6.38% daily) as technical breakout momentum continues following last week's 14% surge, with bulls targeting $15.71 resistance level.
INJ Price Drops 4.68% Despite Strong Ecosystem Growth - Technical Analysis Shows Mixed Signals
Injective (INJ) trades at $15.07 after a 4.68% decline, despite positive ecosystem developments including USDM stablecoin launch and Ondo Finance integration.
Injective (INJ) Surges 6.47% to $15.30 as Strategic Partnerships Drive Bullish Momentum
INJ trades at $15.30 with 6.47% gains as yield-bearing stablecoin integrations and technical breakouts signal continued bullish momentum toward $15.71 resistance.
Injective (INJ) Price Pulls Back to $14.68 Despite Strong Partnership Momentum
INJ trades at $14.68 after a 3.80% daily decline, but technical indicators remain bullish following recent DeFi integration announcements.
Injective (INJ) Pulls Back to $13.56 Despite Bullish ETF Filing and EVM Upgrade News
INJ retreats 7.75% to $13.56 after recent highs, but strong fundamentals from Cboe ETF filing and EVM mainnet launch suggest potential buying opportunity near support.
Injective (INJ) Falls to $13.01 Despite EVM Upgrade and ETF Filing Momentum
INJ drops 8.77% to $13.01 as profit-taking overwhelms recent bullish catalysts from Cboe's staked ETF filing and Ethernia upgrade launch.
Semantic Prompt Injections Challenge AI Security Measures
Recent developments in AI highlight vulnerabilities in multimodal models due to semantic prompt injections, urging a shift from input filtering to output-level defenses.
** Injective (INJ) Price Holds $12.68 Despite Mixed Signals as Ethernia Upgrade Boosts Developer Interest
** INJ trades at $12.68 with neutral RSI at 45.00, testing crucial support near $12.20 while recent Ethernia upgrade and Cboe ETF filing provide bullish catalysts for potential breakout.
Injective (INJ) Price Struggles at $12.39 Despite ETF Filing and EVM Upgrade
INJ trades at $12.39 after a 2.29% decline, testing key support levels despite recent Cboe ETF filing and Ethernia upgrade driving initial optimism.
Injective (INJ) Breaks Above $14 as EVM Upgrade and ETF Filing Drive Bullish Momentum
INJ trades at $14.47 (+2.77% in 24h) following successful Ethernia upgrade and institutional ETF interest, with technical indicators suggesting continued upside potential.
INJ Price Surges 9% as Injective Unveils New Financial Primitive
Injective (INJ) rallies to $16.39 with 9% daily gains following announcement of new financial primitive, breaking above key resistance levels with RSI approaching overbought territory.
Injective (INJ) Battles Volatility as Price Hovers Around $15.27 Amid Recovery Attempts
INJ price currently trades at $15.27 after recovering from recent 30% decline, with technical indicators showing mixed signals as traders eye key resistance at $16.55.
INJ Price Prediction: Targeting $17.40 by Late August 2025 as Bullish Momentum Builds
INJ price prediction shows strong potential to reach $17.40 within two weeks, supported by bullish MACD momentum and analyst consensus targeting upside breakout.
INJ Price Prediction: Targeting $17.59 Short-Term with Bullish Momentum Building
INJ price prediction shows upside potential to $17.59 within 1 week as technical indicators signal bullish momentum despite recent -6.34% decline from current $14.34 level.
Injective (INJ) Rallies 5.27% as Technical Indicators Flash Bullish Signals
INJ price surged to $15.18 today with strong momentum indicators suggesting further upside potential. Technical analysis reveals bullish MACD crossover and RSI in neutral territory.
Injective (INJ) Breaks Above $14 as EVM Upgrade and ETF Filing Drive Bullish Momentum
INJ trades at $14.42 (+1.84%) following Cboe's staked ETF filing and Ethernia Upgrade launch, with technical indicators showing continued bullish strength above key support.
Injective (INJ) Recovers 7.6% to $13.31 Following EVM Upgrade and ETF Filing
INJ rebounds to $13.31 after recent consolidation, as Cboe's staked ETF filing and Ethernia Upgrade provide fundamental catalysts despite short-term profit-taking pressure.
Injective (INJ) Price Struggles Despite Ethernia Upgrade and Staked ETF Filing
INJ trades at $12.79 (-3.47% in 24h) as technical indicators signal bearish momentum despite recent EVM compatibility upgrade and Cboe's first staked INJ ETF filing.
Injective (INJ) Consolidates Near $13 as EVM Upgrade Boosts Developer Interest
INJ trades at $12.96 (+3.19% in 24h) following successful Ethernia upgrade, but faces resistance at $16.35 amid mixed technical signals on daily charts.
INJ Price Analysis: Injective Holds Above Key Support Despite 3% Daily Drop
INJ price trades at $14.17 after a 3.08% decline, but technical indicators suggest bullish momentum remains intact with strong support levels holding firm.
INJ Price Breaks Above Key Moving Averages as Bullish Momentum Builds
INJ trades at $14.32, up 0.56% in 24h, showing strong bullish signals as price holds above all major moving averages with RSI in neutral territory.
Injective (INJ) Price Consolidates at $13.64 as New Financial Primitive Announcement Looms
INJ trades at $13.64 (-5.34% today) with neutral RSI at 50.93. Today's financial primitive reveal could spark breakout above $15.39 resistance toward $20 target.
INJ Price Analysis - August 17, 2025
INJ price prediction shows strong bullish momentum targeting $17.63 short-term and $18+ medium-term as technical analysis reveals breakout potential above $16.55 resistance.
INJ Price Prediction: Targeting $17.40 Breakout Within 2 Weeks as Technical Momentum Builds
INJ price prediction shows potential for 20% upside to $17.40 target as bullish MACD momentum and above-average positioning signal breakout opportunity in coming weeks.
** INJ Price Analysis: Injective Faces Key Test at $14.77 Amid Mixed Technical Signals
** INJ trades at $14.77 (-1.73% daily) as technical indicators show neutral momentum despite recent 20% weekly gains driven by infrastructure adoption and ETF filing news.
INJ Price Prediction: $17.40 Target Within 2 Weeks as Technical Breakout Builds
Injective price prediction shows bullish momentum toward $17.40 short-term target, with analysts forecasting medium-term range of $14.84-$33.53 based on technical indicators.
INJ Price Analysis - August 29, 2025
Despite bearish momentum, INJ price prediction models target $17.40-$21.96 by late August 2025, with analysts forecasting a 31-66% surge from current $13.24 levels.
Injective (INJ) Faces Sharp Decline Amid Exchange Delistings and Regulatory Pressure
INJ trades at $13.24 (-3.92% daily) following 22% crash from regulatory uncertainty and major exchange delistings affecting liquidity and investor sentiment.
INJ Price Prediction: Bearish Momentum Targets $12.04 in Near-Term Decline
Recent INJ price prediction models suggest a potential drop to $12.04 within the next week, as technical indicators align for continued bearish pressure on Injective Protocol.
INJ Price Drops to $12.97 as Regulatory Pressures Mount for Injective Protocol
Injective (INJ) trades at $12.97 after recent regulatory challenges triggered exchange delistings. Technical indicators show mixed signals as INJ RSI sits neutral at 45.41.
INJ Price Prediction: Bearish Momentum Targets $11.94 in Near-Term Despite Long-Term Bullish Structure
INJ price prediction shows bearish pressure toward $11.94 support as technical indicators signal continued downside despite trading above 200-day moving average at $11.83.
INJ Price Prediction: $17.40 Target Within 30 Days Despite Current Bearish Momentum
Injective (INJ) trades at $12.69 with analysts targeting $13.86-$19.75 range. Technical analysis suggests $17.40 upside potential despite short-term bearish signals.
INJ Price Struggles at $12.58 as Exchange Delistings Create Selling Pressure
Injective (INJ) trades at $12.58 after major exchange delistings triggered regulatory concerns, with technical indicators showing mixed signals near key support levels.
INJ Price Rallies 4.43% Despite Regulatory Headwinds - Can Injective Break $16 Resistance?
INJ price climbs to $13.21 amid 4.43% daily gains, but faces regulatory uncertainty and exchange delistings. Technical indicators show mixed signals.
INJ Price Prediction: Targeting $16.19 Resistance with 23% Upside in September 2025
INJ price prediction shows potential 23% rally to $16.19 resistance level, with technical indicators suggesting neutral momentum could shift bullish above $13.64.
INJ Price Prediction: Target $20-25 by October 2025 Despite Current Consolidation
INJ price prediction shows potential 60-100% upside to $20-25 range within 4-6 weeks, supported by oversold conditions and key support holding at $11.91.
INJ Price Prediction: $14.50 Target by October 2025 Despite Mixed Signals
INJ price prediction points to $14.50 target within 4-6 weeks as Injective trades above key support at $13.04, though bearish MACD suggests caution near-term.
Injective (INJ) Consolidates Near $13 as RSI Shows Neutral Territory
INJ price trades at $13.03 with modest 0.70% daily gains as technical indicators suggest consolidation phase with key support at $12.15 and resistance at $15.18.
INJ Price Prediction: Targeting $15.18 Resistance Break with $28+ Long-Term Upside
INJ price prediction shows immediate resistance at $15.18 with potential 15% upside. Injective forecast suggests $28+ long-term target if key levels hold.
Injective (INJ) Breaks Above $13 Despite Regulatory Headwinds - Technical Breakout in Play
INJ trades at $13.28 (+1.69%) as technical analysts spot potential Wave 3 breakout patterns despite recent exchange delistings weighing on sentiment.
INJ Price Surges 5.66% as Injective Launches Revolutionary BUIDL Index
INJ trades at $14.20 (+5.66%) following BlackRock tokenized fund tracking launch. Strong bullish momentum with RSI at 55.32 signals continued upside potential.
INJ Price Prediction: $18-22 Target by October 2025 Amid Bullish Technical Setup
INJ price prediction shows potential 28-57% upside to $18-22 range within 4-6 weeks, supported by bullish MACD momentum and strong positioning above key moving averages.
INJ Breaks Above Key Moving Averages as Injective Shows Strong Bullish Momentum
INJ price sits at $13.97 with bullish MACD signals emerging. Technical indicators suggest potential breakout above $15 resistance as momentum builds.
INJ Price Prediction: Targeting $16.50 Recovery Within 30 Days Despite Near-Term Headwinds
INJ price prediction suggests potential 24% upside to $16.50 resistance, though bearish momentum could test $12.67 support first before Injective forecast turns bullish.
INJ Price Prediction: Targeting $17.40 Breakout in 2-3 Weeks Amid Mixed Technical Signals
INJ price prediction shows potential for $17.40 target within 2-3 weeks, though bearish MACD momentum creates near-term uncertainty around current $13.37 levels.
INJ Price Prediction: Targeting $17.40 in Short-Term with Potential Rally to $21.50
INJ price prediction shows bullish momentum targeting $17.40 near-term, with Injective forecast indicating potential upside to $21.50 by year-end despite current neutral RSI signals.
Injective (INJ) Shows Recovery Signs at $13.83 After Brutal Regulatory Selloff
INJ climbs 3.52% to $13.83 as traders hunt for oversold bounce following devastating 22% regulatory crash and exchange delistings that hammered the token.
Injective (INJ) Price Struggles at $12.95 as Regulatory Uncertainty Weighs on Market
INJ trades at $12.95 (-2.04% today) near Bollinger Band support amid ongoing regulatory concerns despite earlier ETF proposal momentum.
INJ Price Prediction: Targeting $16.55 Resistance in September Despite Bearish Momentum
INJ price prediction suggests a potential move to $16.55 resistance level within 2-3 weeks, but bearish MACD momentum poses downside risks to $12.67 support.
INJ Price Holds $12.98 Despite Exchange Delistings and Regulatory Headwinds
Injective (INJ) trades at $12.98 with neutral RSI at 45.79 as regulatory pressures trigger exchange delistings, creating mixed technical signals for traders.
INJ Price Prediction: Targeting $19-$32 Range as Technical Setup Suggests September Rally
INJ price prediction shows potential for 45-145% gains targeting $19-$32 based on analyst forecasts and technical breakout patterns from current $13.04 level.
Injective (INJ) Struggles Below $13 as Regulatory Headwinds Persist
INJ price trades at $12.88 (-1.38% today) as regulatory uncertainty continues to weigh on sentiment despite analyst predictions of potential triple-digit rallies.
Injective (INJ) Fights for Support at $12.69 Amid Regulatory Headwinds
INJ trades at $12.69 (-1.78%) as regulatory uncertainty weighs on sentiment despite technical analysts spotting potential Wave 3 breakout patterns.
Injective (INJ) Trades at $13.01 as Technical Indicators Show Mixed Signals
INJ price holds above key support at $13.01 with neutral RSI, while MACD signals bearish momentum despite overall bullish trend structure.
INJ Price Prediction: Targeting $16.55 Resistance Break for 20% Upside Within 2 Weeks
INJ price prediction points to $16.55 resistance test within 14 days, with technical indicators showing bullish momentum despite neutral RSI at 52.83.
INJ Price Prediction: Targeting $15.50-$16.20 Within 4-6 Weeks as Technical Breakout Looms
Injective Protocol eyes $15.50 target as bullish momentum builds above $13.04 support, with analysts forecasting potential rally to $16.20 range within next month.
INJ Price Prediction: Targeting $18-20 Range by October 2025 Amid Mixed Analyst Forecasts
Injective (INJ) shows bullish momentum with MACD histogram at 0.1623, targeting $18-20 by October 2025 despite conflicting analyst forecasts ranging from $15 to $51.
Injective (INJ) Reclaims $14 Despite Regulatory Headwinds as Institutional Adoption Surges
INJ trades at $14.16 (+1.22%) showing resilience after Pineapple Financial's $100M investment, while technical indicators suggest bullish momentum despite recent regulatory pressures.
INJ Price Prediction: $16.50 Target Within 30 Days as Technical Indicators Signal Bullish Breakout
INJ price prediction points to $16.50 target by mid-October 2025, with bullish MACD momentum and proximity to upper Bollinger Band suggesting imminent breakout above $14.60 resistance.
Injective (INJ) Surges 4.5% as Network Expansion and Election Futures Drive Momentum
INJ price rallies to $14.80 (+4.52%) as Injective integrates with Klaytn and Bitkub while launching innovative election futures markets on Helix.
INJ Price Prediction: Targeting $16.50-$18.00 by October 2025 Amid Bullish Technical Setup
INJ price prediction suggests upside to $16.50-$18.00 range within 4-6 weeks as technical indicators align bullishly despite recent analyst divergence on targets.
Injective (INJ) Price Tests $14 Support as Technical Indicators Show Mixed Signals
INJ trades at $14.07 (-5.06% in 24h) with RSI at 53.33 showing neutral momentum while MACD histogram suggests underlying bullish pressure may emerge.
INJ Price Prediction: $16.50 Target by October 2025 as Bulls Eye Key Resistance
INJ price prediction targets $16.50 within 4-6 weeks as bullish momentum builds above $14.88 resistance, with technical indicators supporting upside potential.
Injective (INJ) Price Holds $13.60 Despite Technical Warning Signals and $100M Institutional Investment
INJ trades at $13.63 (-3.61% daily) as bullish institutional adoption from Pineapple Financial's $100M investment contrasts with bearish technical patterns.
INJ Price Prediction: Targeting $16.99 by October 2025 with Bullish Technical Setup
INJ price prediction shows potential rally to $16.99-$21.25 range over next month as technical indicators align bullishly despite recent 4% decline.
Injective (INJ) Price Holds Above Key Support as Technical Indicators Turn Neutral
INJ trades at $13.63 with +2.48% daily gains, showing bullish momentum despite RSI remaining neutral at 49.59 as traders eye critical resistance levels.
INJ Price Prediction: Targeting $15-16 Range by October 2025 Despite Mixed Analyst Views
INJ price prediction suggests upside to $15-16 in coming weeks, with technical analysis showing bullish MACD momentum despite neutral RSI at current $13.79 level.
Injective (INJ) Shows Bullish Momentum as Price Holds Above Key Support at $13.69
INJ price trades at $13.69 with +0.74% daily gains. Technical indicators signal potential upside as Injective holds above critical support levels.
INJ Price Surges 6% to $14.58 as Injective Shows Strong Bullish Momentum
Injective (INJ) trades at $14.58 with +5.96% daily gains, approaching upper Bollinger Band resistance while maintaining strong bullish trend signals.
INJ Price Analysis: Injective Shows Bullish Signals Despite Minor Daily Decline
INJ trades at $14.38 with -0.62% daily drop, but strong technical indicators and positive ecosystem developments suggest potential upside momentum ahead.
INJ Price Prediction: Targeting $16.99 by October 2025 as Technical Indicators Signal Bullish Momentum
INJ price prediction points to $16.99 target within 4-6 weeks as MACD histogram shows bullish momentum and analysts converge on upside potential to $21.25.
INJ Price Holds Above $13 as Injective Shows Mixed Technical Signals
Injective (INJ) trades at $13.89 after a 3.48% daily decline, with technical indicators suggesting consolidation before potential breakout above key resistance levels.
INJ Price Consolidates at $13.92 as Technical Indicators Signal Mixed Momentum
Injective (INJ) trades at $13.92 with neutral RSI at 50.93, showing bullish MACD signals while testing key support levels around $12.37.
INJ Price Holds Above $12 Despite Mixed Signals - Technical Breakdown Reveals Critical Levels
Injective (INJ) trades at $12.47 with bearish momentum indicators conflicting with bullish long-term trend as traders eye key support at $11.88.
INJ Price Drops 3.6% as Injective Tests Critical Support at $11.86
Injective (INJ) trades at $11.98 after declining 3.62% in 24 hours, approaching key support levels with bearish momentum indicators signaling potential further downside.
INJ Price Prediction: $15-17 Target Within 30 Days Despite Current Weakness
INJ price prediction shows potential recovery to $15-17 range in October 2025, with current RSI oversold conditions and proximity to Bollinger Band support creating buying opportunity.
INJ Price Prediction: Injective Targets $16.50-$23.00 Range Through November 2025
Current technical setup suggests INJ price prediction favors upside to $16.50 short-term with potential breakout to $23 range if key resistance at $16.55 clears.
INJ Price Plunges 10.5% as Injective Tests Critical Support at $12.06
Injective (INJ) trades at $12.38 after a sharp 10.5% decline, with technical indicators suggesting further downside risk as the token approaches key support levels.
INJ Price Consolidates Near Support as Injective Shows Mixed Technical Signals
INJ trades at $12.51 with bearish momentum indicators, but strong support levels suggest potential reversal opportunities for patient traders.
INJ Price Drops Below Key Moving Averages as Bearish Momentum Builds
Injective (INJ) trades at $11.57 after falling 0.94% in 24 hours, with technical indicators signaling potential further downside as RSI hits oversold territory.
Injective Analysis: Technical Breakdown Shows Mixed Signals as INJ Tests Critical Support
INJ price trades at $12.06 (+4.24%) with technical indicators showing conflicting signals. Key support at $11.14 becomes crucial for bulls defending higher lows.
First Crypto MasterCard CoinJar Card Launches in Australia
Australian cryptocurrency exchange CoinJar cooperated with the global payment giant MasterCard to launch Australia's first cryptocurrency MasterCard CoinJar Card.
Injective Raises $40m Funding to Expand DeFi Applications
Injective is investing in the future of financial technology by creating avenues for diversified and equitable access to financial freedom.
Injective (INJ) Becomes First Non-Ethereum Blockchain to Integrate Ethena's USDe
thena, the prominent DeFi protocol with nearly $1 billion in TVL, expands its ecosystem by launching USDe and Ethena Shards exclusively on the Injective blockchain.
First Bitcoin Mixer Slapped with $60M Fine by FinCEN in Money Laundering Crackdown
FinCEN charged a Bitcoin-mixing operator with a $60 million civil money penalty for violating anti-money laundering regulations.
Demand for Zilliqa Blockchain in Play-to-Earn Games Gains Steam
Zilliqa, a public blockchain that offers solutions to decentralized applications (dapps) and enterprises, is emerging as one of the sought-after networks in the esports industry based on notable partnerships.
Metacade presale stage 5 selling out as strategic partnership with MEXC is confirmed
Metacade, a community-led GameFi project, has gained significant momentum in its presale following the recent announcement of its strategic partnership with leading exchange MEXC. Only 3 presale stages remain before the MCADE token is sold out and officially listed on exchanges.
Mercado Libre Injects Liquidity into Crypto Firms Paxos & 2TM
Mercado Libre, a publicly traded retail giant based in Argentina, has injected an undisclosed sum of money into two regional cryptocurrency-focused firms, Paxos and 2TM Group.
Solana Apps May Soon be Ported to Cosmos Ecosystem
Developers can soon test their Solana Web3 apps for use in Cosmos ecosystem via Injective’s layer-2 testnet, which uses Solana’s Sea Level Virtual Machine. The new layer was created with Eclipse’s help.
US Judge Blocks Trump Administration’s Ban on TikTok Downloads
A federal US judge granted an injunction request against the Trump Administration’s order to ban TikTok downloads across all US app stores.
Telegram Maintains Gram is not a Security, Urges Court to Deny SEC Action
Telegram, in an October 16th filing, has asked the Southern District Court of New York to deny the request by the United States Securities and Exchange Commission for a preliminary injunction on Gram, Telegram’s native cryptocurrency.
Ripple Handed a Temporary Restraining Order Limiting XRP Sales until Investor Tetragon Has Sold Back Its Shares
After a court ruling, a temporary restraining order has been issued against Ripple limiting its XRP sales.
SEC Fights Telegram on Gram Token Sale at US Court Battle
The cryptocurrency and blockchain community have been closely watching the court case between the United States Securities and Exchange Commission and Telegram over the legality of the latter’s $1.7 billion token offering.
Chinese Banks Clarify on Crypto Account Freezing Despite Alipay’s Crypto Ban Last Year
China’s banks were rumored to be freezing client accounts that have a history associated with the buying and selling of cryptocurrencies. However, according to a recent report, Chinese banks have clarified that this is not the case, and they are not shutting down any legal fiat to crypto accounts.
CFTC Charges Four Individuals Behind Alleged Bitcoin Fraud Scheme "Global Trading Club"
The Commodity Futures Trading Commission has charged four people for allegedly soliciting funds from clients to speculate in Bitcoin price movements.
ConsenSys Sued For IP Theft by Blockchain Startup from its Own Incubator
BlockCrushr, a Canadian blockchain firm has accused ConsenSys of stealing its intellectual property after it took part in a ConsenSys’ startup accelerator program.
Telegram Tells US Investors to Leave TON Blockchain Project and Take 72% Refund
Telegram now says US investors won’t get 110% refund and tells them to leave its blockchain TON project.
Ripple Sued by One of Its Major Investors Demanding The Blockchain Firm Reclaim Its Stock
Things look grim for Ripple as Tetragon, a former investor in the company, has turned against it, filing a complaint against the fintech firm.
Telegram Issues Letter to Investors After SEC Files Restraining Order and Sets Hearing on Oct. 24
Telegram Open Network (TON) developers responded to investors in a letter regarding the United States Securities and Exchange Commission (SEC) announcing that the GRM token offering was illegal. GRM is a native currency of TON, the blockchain platform that aims at facilitating payments and hosting decentralized applications (DApps).